ANNEX A: SUMMARY OF 2024 FHSIS INDICATORS

Indicators/Program Office Responsible

A. Family Planning DPCB

B. Maternal Care Prenatal DPCB

C. Maternal Care Intrapartum DPCB

D. Maternal Care Postnatal DPCB

E. Child Care Immunization for Infants and Children DPCB

F. Child Care Immunization for School-Aged Children DPCB

G. Child Care Nutrition DPCB

H. Child Care Management of Sick Infants and Children DPCB

I. Oral Health Care DPCB

J. Non-Communicable Diseases (Lifestyle Related) DPCB

K. Non-Communicable Diseases (Cancer Prevention and Control) DPCB

L. Non-Communicable Diseases (Cardiovascular Disease Prevention and Control) DPCB

M. Non-Communicable Diseases (Diabetes Mellitus Prevention and Control) DPCB

N. Non-Communicable Diseases (Blindness Prevention Program) DPCB

O. Non-Communicable Diseases (Immunization for Senior Citizens) DPCB

P. Infectious Diseases Filariasis DPCB

Q. Infectious Diseases Schistosomiasis DPCB

R. Infectious Diseases Soil Transmitted Helminthiasis DPCB

S. Infectious Diseases HIV-AIDS/STI DPCB

T. Infectious Diseases Tuberculosis (source of data: ITIS) DPCB

U. Infectious Diseases Leprosy DPCB

V. Infectious Diseases Rabies DPCB

W. Environmental Health and Sanitation HPB

X. Mortality DPCB

Y. Natality DPCB

Z. Demographic EB

AA. Morbidity EB

1
 Indicator Formula Target

A. Family Planning

No. of New Acceptors Sum of all WRA who are new acceptors of FP method N/A

No. of Current Users Formula for CU at End of Month/ Quarter N/A

= CU of previous
month
+ New Acceptor of
previous month
+ Other acceptors
of present month
- Drop-out of
present month

No. of Other Acceptors

No. of Drop-outs Sum of all MFP users who dropped out N/A

Demand Satisfied with Modern Numerator: No target

Family Planning Methods Total number of WRA who are currently using, or whose partner is currently using,
any modern FP methods during a given period.

Denominator:
Total demand for family planning (the sum of the number of women using any
contraceptive method (CPAny) and the number of women with unmet need for
family planning (UMN)) multiplied with the Women of Reproductive Age

B. Maternal Care Prenatal

Proportion of women who gave Numerator: 95%

birth with at least 4 prenatal a. Number of pregnant women 10-14 years old with at least 4 prenatal
check-ups check-ups
b. Number of pregnant women 15-19 years old with at least 4 prenatal
check-ups
c. Number of pregnant women 20-49 years old with at least 4 prenatal
check-ups

Denominator a,b,c:
a. Total deliveries 10-14 years old
b. Total deliveries 15-19 years old
c. Total deliveries 20-49 years old

Proportion of pregnant women Numerator 1: <30%

according to their nutritional status Number of pregnant women seen in the first trimester who have normal BMI
a. 10-14 years old
b. 15-19 years old
c. 20-49 years old

Numerator 2:
Number of pregnant women seen in the first trimester who have low BMI <5%
a. 10-14 years old
b. 15-19 years old

2
 Indicator
Proportion of women pregnant for
the first time given at least 2
doses of Tetanus diphtheria (Td)
vaccination
Proportion of women pregnant for
the 2nd or more times given at
least 3 doses of Td vaccination
(Td2 Plus)
Proportion of pregnant women
who completed the dose of iron
with folic acid or Multiple
Micronutrient supplementation
Proportion of pregnant women
who completed doses of calcium
carbonate supplementation
Formula Target
c. 20-49 years old
Numerator 3:
Number of pregnant women seen in the first trimester who have high BMI No target
a. 10-14 years old
b. 15-19 years old
c. 20-49 years old
Denominator 1,2,3:
Eligible population under 1
Numerator: 95%
a. Number of 10-14 years old pregnant women for the first time given at least
2 doses of Td vaccination
b. Number of 15-19 years old pregnant women for the first time given at least
2 doses of Td vaccination
c. Number of 20-49 years old pregnant women for the first time given at least
2 doses of Td vaccination
Denominator a,b,c:
Eligible population under 1
Numerator: 95%
a. Number of 10-14 years old pregnant women for the 2nd or more times
given at least 3 doses of Td vaccination (Td2 Plus)
b. Number of 15-19 years old pregnant women for the 2nd or more times
given at least 3 doses of Td vaccination (Td2 Plus)
c. Number of 20-49 years old pregnant women for the 2nd or more times
given at least 3 doses of Td vaccination (Td2 Plus)
Denominator a,b,c:
Eligible population under 1
Numerator: 95%
a. Number of pregnant women 10-14 years old who completed the dose of
iron with folic acid supplementation
b. Number of pregnant women 15-19 years old who completed the dose of
iron with folic acid supplementation
c. Number of pregnant women 20-49 years old who completed the dose of
iron with folic acid supplementation
Denominator a,b,c:
Eligible population under 1
Numerator: 30%
a. Number of pregnant women 10-14 years old who completed doses of
calcium carbonate supplementation
b. Number of pregnant women 15-19 years old who completed doses of
calcium carbonate supplementation
c. Number of pregnant women 20-49 years old who completed doses of
calcium carbonate supplementation
Denominator a,b,c:
Eligible population under 1
3
 Indicator Formula Target

Proportion of pregnant women Numerator: 95%

given one dose of deworming a. Number of pregnant women 10-14 years old given one dose of deworming
tablet tablet
b. Number of pregnant women 15-19 years old given one dose of deworming
tablet
c. Number of pregnant women 20-49 years old given one dose of deworming
tablet

Denominator a,b,c:
Eligible population under 1

Proportion of pregnant women Numerator: 95%

screened for Hepatitis B a. Number of pregnant women 10-14 years old screened for Hepatitis B
b. Number of pregnant women 15-19 years old screened for Hepatitis B
c. Number of pregnant women 20-49 years old screened for Hepatitis B

Denominator a,b,c:
Eligible population under 1

Proportion of pregnant women Numerator: No target

tested positive for Hepatitis B a. Number of pregnant women 10-14 years old tested positive for Hepatitis B
b. Number of pregnant women 15-19 years old tested positive for Hepatitis B
c. Number of pregnant women 20-49 years old tested positive for Hepatitis B

Denominator a,b,c:
Total number of pregnant women screened for Hepatitis B

Proportion of pregnant women Numerator: 95%

tested for complete blood count
(CBC) or Hemoglobin (Hgb) &
Hematocrit (Hct) count
a. Number of pregnant women 10-14 years old tested for CBC or Hgb&Hct
count
b. Number of pregnant women 15-19 years old tested for CBC or Hgb&Hct
count
c. Number of pregnant women 20-49 years old tested for CBC or Hgb&Hct
count

Denominator a,b,c:
Eligible population under 1

Proportion of pregnant women Numerator: No target

tested for complete blood count or a. Number of pregnant women 10-14 years old diagnosed with anemia
Hgb&Hct count diagnosed with b. Number of pregnant women 15-19 years old diagnosed with anemia
anemia c. Number of pregnant women 20-49 years old diagnosed with anemia

Denominator a,b,c:
Number of pregnant women tested for CBC or Hgb&Hct count

Proportion of pregnant women Numerator: 95%

screened for gestational diabetes
a. Number of pregnant women 10-14 years old screened for gestational
diabetes
b. Number of pregnant women 15-19 years old screened for gestational
diabetes
c. Number of pregnant women 20-49 years old screened for gestational
diabetes

Denominator a,b,c:
Eligible population under 1

4
 Indicator
Proportion of pregnant women
tested positive for gestational
diabetes
C. Maternal Care Intrapartum
Total number of deliveries
Proportion of live births by
birth weight
Proportion of deliveries attended
by skilled health professionals
Proportion of facility-based
deliveries
Proportion of deliveries by type
(vaginal or cesarean section)
Formula Target
Numerator: No target
a. Number of pregnant women 10-14 years old tested positive for gestational
diabetes
b. Number of pregnant women 15-19 years old tested positive for gestational
diabetes
c. Number of pregnant women 20-49 years old tested positive for gestational
diabetes
Denominator a,b,c:
Number of pregnant women screened for gestational diabetes
Sum of all deliveries based on actual count N/A
Numerator 1: N/A
a. Number of live births with normal birth weight (> 2500 grams)
b. Number of live births with low birth weight (< 2500 grams)
c. Number of live births with unknown birth weight
Denominator a,b,c:
Total number of live births
Numerator: 90%
a. Number of deliveries of women attended by physicians
b. Number of deliveries of women attended by nurses
c. Number of deliveries of women attended by midwives
Denominator a,b,c:
Total number of deliveries
Numerator: 90%
a. Number of deliveries in public health facility
b. Number of deliveries in private health facility
Denominator a,b:
Total number of deliveries
Numerator 1: No target
Number of vaginal deliveries among women
a. 10-14 years old
b. 15-19 years old
c. 20-49 years old
Numerator 2:
Number of deliveries via caesarian section among women
a. 10-14 years old
b. 15-19 years old
c. 20-49 years old
Denominator 1,2:
Total number of deliveries
5
 Indicator Formula Target

Proportion of pregnancy by A. No target

outcome Numerator 1:
Number of full-term births among women
a. 10-14 years old
b. 15-19 years old
c. 20-49 years old

Numerator 2:
Number of pre-term births among women
a. 10-14 years old
b. 15-19 years old
c. 20-49 years old

Numerator 3:
Number of fetal deaths among women
a. 10-14 years old
b. 15-19 years old
c. 20-49 years old

Denominator:
Total number of deliveries

B.
Number of abortions among women (counts only)
a. 10-14 years old
b. 15-19 years old
c. 20-49 years old

D. Maternal Care Postnatal

Proportion of post-partum women Numerator: 95%

together with their newborn who
completed at least 2 postpartum
check-ups
a. Number of post-partum women 10-14 years old together with their
newborn who completed at least 2 postpartum check-ups
b. Number of post-partum women 15-19 years old together with their
newborn who completed at least 2 postpartum check-ups
c. Number of post-partum women 20-49 years old together with their
newborn who completed at least 2 postpartum check-ups

Denominator:
a. Total deliveries 10-14 years old
b. Total deliveries 15-19 years old
c. Total deliveries 20-49 years old

Proportion of post-partum women Numerator: 95%

who completed iron with folic acid
supplementation
a. Number of postpartum women 10-14 years old who completed iron with
folic acid supplementation
b. Number of postpartum women 15-19 years old who completed iron with
folic acid supplementation
c. Number of postpartum women 20-49 years old who completed iron with
folic acid supplementation

Denominator a,b,c:
Eligible population under 1

6
 Indicator Formula Target

Proportion of post-partum women Numerator: 85%

with Vitamin A supplementation
a. Number of postpartum women 10-14 years old with Vitamin A
supplementation
b. Number of postpartum women 15-19 years old with Vitamin A
supplementation
c. Number of postpartum women 20-49 years old with Vitamin A
supplementation

Denominator a,b,c:
Eligible population under 1

E. Child Care Immunization for Infants and Children

Proportion of newborn / infants Numerator: 95%

vaccinated with BCG antigen Number of newborn / infants vaccinated with BCG antigen

Denominator:
Eligible population 0-11 months

Proportion of newborn vaccinated Numerator: 95%

with Hepatitis B antigen within 24 Number of newborn vaccinated with birth dose of HepB antigen within 24 hours
hours after birth
Denominator:
Eligible population 0-11 months

Proportion of children protected at Numerator: No target

birth (CPAB) from neonatal Number of newborns whose mothers pregnant for the first time who have received
tetanus at least 2 doses of TT/Td vaccination at least a month prior to delivery PLUS
number of newborns whose mothers pregnant for the 2nd or more times have
received at least 3 doses of TT/Td

Denominator:
Eligible population 0-11 months

Proportion of Infants who Numerator: 95%

completed 3 doses of Number of infants vaccinated with
DPT-HiB-HepB antigen a. DPT-HiB-HepB 1 antigen
b. DPT-HiB-HepB 2 antigen
c. DPT-HiB-HepB 3 antigen

Denominator a,b,c:
Eligible population 0-11 months

Proportion of Infants who Numerator: 95%

completed 3 doses of Oral Polio Number of infants vaccinated with
Vaccine (OPV) a. OPV1 antigen
b. OPV2 antigen
c. OPV3 antigen

Denominator a,b,c:
Eligible population 0-11 months

7
 Indicator Formula Target

Proportion of infants who Numerator: 95%

completed 2 doses of Inactivated Number of infants vaccinated with
Polio Vaccine (IPV) a. IPV1 antigen
b. IPV2 antigen (Routine)

Denominator a,b:
a. Eligible population 0-11 months
b. Eligible population 0-11 months

Proportion of Infants who Numerator: 95%

completed 3 doses of Number of infants vaccinated with
Pneumococcal Conjugate Vaccine a. PCV1 antigen
(PCV) b. PCV2 antigen
c. PCV3 antigen

Denominator a,b,c:
Eligible population 0-11 months

Proportion of Children vaccinated Numerator: 95%

with 2 doses of Measles Number of children vaccinated with
Containing Vaccine (MCV) a. MCV1 antigen
b. MCV2 antigen

Denominator:
a. Eligible Population 0-11 months (MCV1)
b. Eligible population 0-12 months (MCV2)

Proportion of Fully-Immunized Numerator: 95%

Children (FIC) Number of Fully Immunized Children

Denominator:
Eligible Population 0-12 months

Proportion of Completely Numerator: No target

Immunized Children (CIC) Number of Completely Immunized Child

Denominator:
Eligible population 13-23 months

F. Child Care Immunization for School-Aged Children

Proportion of Grade 1 and Grade Numerator: 95%

7 learners given one dose of a. Number of Grade 1 learners given Td
Tetanus diphtheria toxoid (Td) b. Number of Grade 7 learners given Td
vaccine
Denominator:
a. Number of enrolled Grade 1 learners
b. Number of enrolled Grade 7 learners

Proportion of Grade 1 and Grade Numerator: 95%

7 learners given one dose of a. Number of Grade 1 learners given MR
Measles Rubella (MR) vaccine b. Number of Grade 7 learners given MR

Denominator:
a. Number of eligible Grade 1 learners enrolled
b. Number of eligible Grade 7 learners enrolled

8
 Indicator
G. Child Care Nutrition
Proportion of newborns who were
initiated on breastfeeding within 1
hour after birth
Proportion of infants born preterm
or with low birth weight given iron
supplements
Proportion of infants exclusively
breastfed until 5th month and 29
days
Proportion of infants who
continued breastfeeding and were
introduced to complementary
feeding beginning at 6 months of
age
Proportion of infants / children
who completed Vitamin A
supplementation
Proportion of infants 6-11 months
old and children 12-23 months old
who completed Micronutrient
Powder (MNP) or Lipid-Based
Nutrient Supplement – Small
Quantity (LNS-SQ)
supplementation
Proportion of 0-59 months old
who are
● Stunted
● Wasted-MAM
● Wasted-SAM
● Overweight/ Obese
● Normal
Formula Target
Numerator: 95%
Number of newborns who were initiated on breastfeeding within 1 hour after birth
Denominator:
Total number of live births
Numerator: 95%
Number of preterm infants and/or infants with low birth weight (less than 2500
grams) given iron supplement starting 1 month until 3 months
Denominator:
Total number of live births with low birth weight (taken from Maternal Care TCL)
Numerator: At least 50%
Number of infants age 5 months and 29 days old who have been exclusively
breastfed from birth until 5th month and 1 day before the child turns 6 months
Denominator:
Eligible population 6 months
Numerator: 955
Number of infants who continued breastfeeding and were introduced to
complementary feeding beginning at 6 months of age
Denominator:
Eligible population 6-11 months
Numerator: 95%
a. Number of Infant 6-11 months old who completed 1 dose of Vitamin A
supplementation
b. Number of children with ages 12-59 months old who completed 2 doses
Vitamin A Supplementation
Denominator:
a. Eligible population 6-11 months
b. Eligible population 12-59 months
Numerator 1: 95%
a. Number of infants 6-11 months old who completed MNP or Lipid-Based
Nutrient Supplement – Small Quantity (LNS-SQ) supplementation.
b. Number of children 12-23 months old who completed MNP or Lipid-Based
Nutrient Supplement – Small Quantity (LNS-SQ) supplementation
Denominator:
a. Eligible population 6-11 months
b. Eligible population 12-23 months
Numerator 1: No target
a. Number of infants and children 0-59 months old who are stunted
b. Number of infants and children 0-59 months old who have moderate acute
malnutrition (MAM)
c. Number of infants and children 0-59 months old who have severe acute
malnutrition (SAM)
d. Number of infants and children 0-59 months old who are overweight/obese
e. Number of infants and children 0-59 months old who have normal weight
for length/height for age measurement
9
 Indicator Formula Target

Denominator a,b,c,d,e:
Total number of children 0-59 months old seen during the reporting period at health
facilities

Proportion of MAM children age Numerator: a. >90%

0-59 months old a. Number of MAM children 0-59 months enrolled in SFP b. >75%
c. <15%
a) admitted in Supplementary Denominator: d. <3%
Feeding Program (SFP) a. Total number of MAM children 0-59 months identified
b) cured
c) defaulted Numerator:
d) died b. Number of MAM children 0-59 months cured in SFP
c. Number of MAM children 0-59 months defaulted in SFP
d. Number of MAM children 0-59 months died in SFP

Denominator b,c,d:
Total number of MAM children 0-59 months discharged in SFP

Proportion of SAM children Numerator: 100%

without complication age 0-59 a. Number of SAM children 0-59 months without complication admitted in
months old OTC

a) admitted in Out-Patient Denominator:

Therapeutic Center (OTC) a. Total number of SAM children 0-59 months identified in OTC
b) cured
c) defaulted Numerator:
d) died b. Number of SAM children 0-59 months without complication cured in OTC
c. Number of SAM children 0-59 months without complication defaulted in
OTC
d. Number of SAM children 0-59 months without complication died in OTC

Denominator b,c,d:
Total number of SAM children 0-59 months discharged in OTC

H. Child Care Management of Sick Infants and Children

Proportion of high-risk infants and Numerator: 100%

children with measles and/or a. Number of sick infants 6-11 months old who received Vitamin A capsule
persistent diarrhea who received aside from routine supplementation
Vitamin A capsule aside from b. Number of sick children 12-59 months old who received Vitamin A capsule
routine supplementation aside from routine supplementation

Denominator:
a. Total number of sick infants 6-11 months old seen
b. Total number of sick children 12-59 months old seen

Proportion of diarrhea cases 0-59 Numerator: 100%

months old who received oral a. Number of diarrhea cases 0-59 months old who received oral rehydration
rehydration salt solution (ORS) salt solution (ORS)
and ORS with zinc drops/syrup b. Number of diarrhea cases 0-59 months old who received oral rehydration
salt solution (ORS) with zinc drops/syrup

Denominator a,b:
Total number of acute diarrhea cases 0-59 months old seen

10
 Indicator Formula Target

Proportion of pneumonia cases Numerator: 100%

among children 0-59 months old Number of pneumonia cases 0-59 months old who received treatment
who received treatment
Denominator:
Total number of pneumonia cases 0-59 months old seen

I. Oral Health Care

Proportion of children 12-59 Numerator: 100% of

months old who are orally fit upon
oral examination or after oral
rehabilitation
Number of orally fit children 12-59 months old upon oral examination plus orally fit service target
after rehabilitation
Denominator:
Eligible population 12-59 months x 20% (service target)

Proportion of clients 5 years old Numerator: No target

and above with cases of Number of cases of 5 years old and above with DMFT
Decayed-Missing Filled Teeth
(DMFT) Denominator:
Total number of clients 5 years old and above examined

Proportion of infants 0-11 months Numerator: 100%

old who received BOHC Number of infants 0-11 months old who received BOHC

Denominator:
Eligible population under 1 x 30% (service target)

Proportion of children 1-4 years Numerator: 100%

old (12-59 months) who received Number of children 1-4 years old (12-59 months) who received BOHC
BOHC
Denominator:
Eligible population 1-4 years old x 30% (service target)

Proportion of children 5-9 years Numerator: 100%

old who received BOHC Number of children 5-9 years old who received BOHC

Denominator:
Eligible population 5-9 years old x 30% (service target)

Proportion of adolescents 10-14 Numerator: 100%

and 15-19 years old who received a. Number of adolescents 10-14 years old who received BOHC
BOHC b. Number of adolescents 15-19 years old who received BOHC

Denominator:
a. Eligible population 10-14 years old x 30% (service target)
b. Eligible population 15-19 years old x 30% (service target)

Proportion of adults 20-59 years Numerator: 100%

old who received BOHC Number of adults 20-59 years old who received BOHC

Denominator:
Eligible population 20-59 years old x 30% (service target)

Proportion of senior citizens 60 Numerator: 100%

years old and above who received Number of senior citizens 60 years old and above who received BOHC
BOHC
Denominator:
Eligible population 60 years old and above x 30% (service target)

11
 Indicator
Proportion of pregnant women
who received BOHC
J. Non-Communicable Diseases (Lifestyle Related)
Proportion of adult (20-59 years
old) and elderly (60 years old and
above) who were risk assessed
using the PhilPEN protocol
Proportion of adult (20-59 years
old) and elderly (60 years old and
above) who are current smokers
based on the PhilPEN protocol
Proportion of adult (20-59 years
old) and elderly (60 years old and
above) who are binge drinkers
based on the PhilPEN protocol
Proportion of adult (20-59 years
old) and elderly (60 years old and
above) who are overweight or
obese
K. Non-Communicable Diseases (Cancer Prevention and Control)
Proportion of women 20 years old
and above screened for cervical
cancer using Visual Inspection
with Acetic Acid (VIA) or Pap
Smear
Formula Target
Numerator: 50%
a. Number of pregnant women age 10-14 years old who received BOHC
b. Number of pregnant women age 15-19 years old who received BOHC
c. Number of pregnant women age 20-49 years old who received BOHC
Denominator a,b,c:
Eligible population under 1
Numerator: 30%
a. Number of adult 20-50 years old who were risk assessed using the
PhilPEN protocol
b. Number of elderly 60 years old and above who were risk assessed using
the PhilPEN protocol
Denominator:
a. Eligible population 20-59 years old
b. Eligible population 60 years old and above
Numerator: No target
a. Number of current smokers 20-59 years old
b. Number of current smokers 60 years old and above
Denominator:
a. Total number of adults 20-59 years old who were risked-assessed using
the PhilPEN protocol
b. Total number of adults 60 years old and above who were risked-assessed
using the PhilPEN protocol
Numerator: No target
c. Number of adults 20-59 years old who are binge drinkers
d. Number of elderly 60 years old and above who are binge drinkers
Denominator:
a. Total number of adults 20-59 years old who were risked-assessed using
the PhilPEN protocol
b. Total number of adults 60 years old and above who were risked-assessed
using the PhilPEN protocol
Numerator: No target
a. Number of adults 20-59 years old who are obese or overweight
b. Number of elderly 60 years old and above who are obese or overweight
Denominator:
a. Total number of adults 20-59 years old who were risked-assessed using
the PhilPEN protocol
b. Total number of adults 60 years old and above who were risked-assessed
using the PhilPEN protocol
Numerator: 70%
Number of women 20 years old and above screened for cervical cancer using VIA
or Pap Smear
Denominator:
Eligible population 20 years old and above (female only)
12
 Indicator Formula Target

Proportion of women 20 years old Numerator: No target

and above found positive or Number of women 20 years old and above found positive or suspect for cervical
suspect with cervical cancer cancer using VIA
among those screened
Denominator:
Total number of women 20 years old and above screened for cervical cancer using
VIA

Proportion of women 20 years old Numerator: No Target

and above with suspicious breast Number of women 20 years old and above with suspicious breast mass
mass
Denominator:
Total number of women 20 years old and above screened for breast mass

L. Non-Communicable Diseases (Cardiovascular Disease Prevention and Control)

Proportion of identified Numerator: No Target

hypertensive adults (20-59 years a. Number of identified hypertensive 20-59 years old adults
old) and elderly (60 years old and b. Number of identified hypertensive 60 years old and above
above)
Denominator:
a. Total number of adults 20-59 years old who were risked-assessed using
the PhilPEN protocol
b. Total number of adults 60 years old and above who were risked-assessed
using the PhilPEN protocol

Proportion of identified Numerator: No Target

hypertensive adults (20-59 years a. Number of identified hypertensive aged 20-59 years old provided with
old) and elderly (60 years old and Antihypertensive medications
above) provided with b. Number of identified hypertensive aged 60 years old and above provided
antihypertensive medications. with Antihypertensive medications

Denominator:
a. Total number of identified hypertensive aged 20-59 years old
b. Total number of identified hypertensive aged 60 years old and above

M. Non-Communicable Diseases (Diabetes Mellitus Prevention and Control)

Proportion of identified adults Numerator: No Target

(20-59 years old) and elderly (60 c. Number of identified 20-59 years old adults with Type 2 Diabetes Mellitus
years old and above) with Type 2 d. Number of identified 60 years old and above with Type 2 Diabetes Mellitus
Diabetes Mellitus
Denominator:
a. Total number of adults 20-59 years old who were risked-assessed using
the PhilPEN protocol
b. Total number of adults 60 years old and above who were risked-assessed
using the PhilPEN protocol

Proportion of identified Type 2 Numerator: No Target

Diabetes Mellitus adults (20-59 a. Number of identified Type 2 Diabetes Mellitus aged 20-59 years old
years old) and elderly (60 years provided with diabetes medications
old and above) provided with b. Number of identified Type 2 Diabetes Mellitus aged 60 years old and
diabetes medications above provided with diabetes medications

Denominator:
a. Total number of identified Type 2 Diabetes Mellitus aged 20-59 years old
b. Total number of identified Type 2 Diabetes Mellitus aged 60 years old and
above

13
 Indicator Formula Target

N. Non-Communicable Diseases (Blindness Prevention Program)

Proportion of senior citizens 60 Numerator: 30%

years old and above screened for Number senior citizens 60 years old and above screened for visual acuity
visual acuity
Denominator:
Eligible population 60 years old and above

Proportion of senior citizens 60 Numerator: No target

years old and above diagnosed Number of senior citizens 60 years old and above diagnosed with eye disease/s
with eye disease/s
Denominator:
Total number of senior citizens 60 years old and above screened for eye problems

O. Non-Communicable Diseases (Immunization for Senior Citizens)

Proportion of senior citizens 60 Numerator: No target

years old and above who received Number of senior citizens 60 years old above who received 1 dose of PPV
1 dose of pneumococcal
polysaccharide vaccine (PPV) Denominator
Eligible population 60 years old and above

Proportion of senior citizens 60 Numerator: No target

years old and above who received Number of senior citizens 60 years old above who received 1 dose of influenza
1 dose of influenza vaccine vaccine

Denominator
Eligible population 60 years old and above

P. Infectious Diseases Filariasis

Case Detection Rate of lymphatic Numerator: Prevalence of

filariasis in endemic provinces Number of individuals examined found positive for lymphatic filariasis lymphatic
filariasis -
Denominator: Less than 1%
Total number of individuals examined for lymphatic filariasis

Clinical Rate of lymphatic filariasis Numerator: No target

Number of lymphatic filariasis cases examined with disabilities/deformities

Denominator:
Total number of cases with lymphatic filariasis

Q. Infectious Diseases Schistosomiasis

Proportion of suspected Numerator: No target

schistosomiasis cases seen Number of suspected cases

Denominator:
Total number of patients seen

Proportion of acute clinically Numerator: No target

diagnosed cases seen Number of acute clinically diagnosed cases

Denominator:
Total number of suspected cases seen

14
 Indicator Formula Target

Proportion of acute confirmed Numerator: No target

cases Number of acute cases confirmed positive by stool examination (Kato-Katz
technique) in the health facility

Denominator:
Total number of acute clinically diagnosed cases

Proportion of chronic clinically Numerator: No target

diagnosed cases seen Number of chronic clinically diagnosed cases

Denominator:
Total number of suspected cases seen

Proportion of confirmed chronic Numerator: No target

cases Number of chronic clinically diagnosed cases confirmed by stool examination (KKT)
or rectal biopsy

Denominator:
Total number of chronic clinically diagnosed cases

Proportion of chronic clinically Numerator: 100%

diagnosed cases treated Number of chronic clinically diagnosed cases treated in the health facility

Denominator:
Total number of confirmed cases (acute and chronic)

Proportion of confirmed chronic Numerator: No target

cases referred to hospital facility Number of confirmed chronic cases referred to a hospital facility

Denominator:
Total number of confirmed chronic cases

R. Infectious Diseases Soil Transmitted Helminthiasis

Proportion of PSAC, 12-59 Numerator: 85%

months old, who completed 2 Number of 1-4 years old (12-59 months old) who completed 2 doses of deworming
doses of deworming tablet tablet in a year

Denominator:
Eligible population 1-4 years old

Proportion of SAC, 5-9 years old, Numerator: 85%

who completed 2 doses of Number of 5-9 years old who completed 2 doses of deworming tablet in a year
deworming tablet
Denominator:
Eligible population 5-9 years old

Proportion of Adolescents, 10-19 Numerator: 85%

years old, who completed 2 doses Number of SAC, 10-19 years old who completed 2 doses of deworming tablet in a
of deworming tablet year

Denominator:
Eligible population 10-19 years old

15
 Indicator Formula Target

Proportion of WRA, 20-49 years Numerator: 85%

old, who completed 2 doses of Number of WRA 20-49 years old who completed 2 doses of deworming tablet in a
deworming tablet year

Denominator:
Eligible population 20-49 years old (female only)

Proportion of pregnant women Numerator: 85%

who completed 1 dose of Number of pregnant women who completed 1 dose of deworming tablet in a year
deworming tablet
Denominator:
Eligible population under 1

S. Infectious Diseases HIV-AIDS/STI

Proportion of pregnant women Numerator: 95%

screened for syphilis Number of pregnant women screened for syphilis

Denominator:
Eligible population under 1

Proportion of pregnant women Numerator: No target

tested positive for syphilis Number of pregnant women tested positive with syphilis

Denominator:
Total number of pregnant women screened for syphilis

Proportion of pregnant women Numerator 95%

tested for HIV Number of pregnant women screened for HIV

Denominator:
Eligible population under 1

T. Infectious Diseases Tuberculosis (source of data: ITIS)

TB Case Notification, All Forms Numerator: 10% Increase

Number of registered new and relapse TB cases (and cases with unknown previous from previous
TB treatment history), all forms (bacteriologically confirmed plus clinically year
diagnosed, pulmonary and extrapulmonary) in the reporting period

Denominator: none

Drug Resistant TB Notifications Numerator: 10% Increase

Number of registered bacteriologically confirmed drug resistant TB (RR/MDR-TB from previous
Cases) year

Denominator: none

Treatment Success Rate (TSR), Numerator: 90%

DSTB-all forms Total Number of TB, all forms that are cured and completely treated

Denominator:
Total Number of TB, all forms registered during a specified period

16
 Indicator Formula Target

Treatment Success Rate (TSR), Numerator: 90%

MDRTB Total Number of registered bacteriology confirmed drug resistant TB Cases
(RR/MDR-TB) cured and completed treatment

Denominator:
Total Number of registered bacteriologically confirmed drug resistant TB cases
(RR/MDR-TB) during a specified period

U. Infectious Diseases Leprosy

Leprosy Prevalence Rate Numerator: Less than

Total number of leprosy cases on treatment during reporting period one case per
10,000
Denominator: population
Total Population

Case Detection Rate Numerator: Bench mark:

Number of newly detected cases during reporting period Less than 5%
from previous
Denominator: year
Total Population

V. Infectious Diseases Rabies

Proportion of deaths due to Numerator: No target

Rabies Number of deaths due to rabies

Denominator:
Total number of Animal Bites

W. Environmental Health and Sanitation

Proportion of households with Numerator: > 92.49%

access to basic safe water supply Total number of households with access to improved water supply such as Level I,
II and III

Denominator:
Projected number of Households for the given year

Proportion of households using Numerator: > 73.62%

safely managed drinking-water Total number of households using drinking water from an improved water source
services that is accessible on premises, available when needed and free from fecal and/or
priority chemical contamination

Denominator:
Projected number of Households for the given year

Proportion of Households with Numerator: > 89.09%

Basic Sanitation Facility Total number of households with improved facilities which are not shared with other
households

Denominator:
Projected number of Households for the given year

17
 Indicator Formula Target

Proportion of Households using Numerator: > 74.58%

safely managed sanitation Total number of households using improved facilities that are not shared with other
services households and where excreta are safely disposed of in situ or removed and
treated offsite

Denominator:
Projected number of Households for the given year

Proportion of Municipality/City Numerator: > 89.09%

declared zero open defecation Number of municipalities and chartered cities certified as ZOD area
(ZOD)
Denominator:
Total number of municipalities and chartered cities

X. Mortality

Maternal Mortality Ratio (MMR) Numerator: 70 maternal

Number of maternal deaths deaths per
100,000 live
Denominator: births
Total number of live births

Under-Five Mortality Rate (UFMR) Numerator: 25 under-five

Number. of deaths among children under 5 years of age (0-59 months old) deaths per
1,000 live
Denominator: births
Total number of live births

Infant Mortality Rate (IMR) Numerator: 17 infant

Number of infant deaths (below 12 months of age or 0 up to 11 months and 29 days deaths per
old) 1,000 live
births
Denominator:
Total number of live births

Neonatal Mortality Rate (NMR) Numerator: 12 neonatal

Number of neonatal deaths deaths per
1,000 live
Denominator: births
Total number of live births

Perinatal Mortality Rate (PMR) Numerator: 18 perinatal

Number of fetal deaths PLUS number of early neonatal deaths deaths per
1,000 live
Denominator: births
Number of live births PLUS number of fetal deaths of 20 or more completed weeks
age of gestation

Y. Natality

Adolescent Birth Rate Numerator: No target

Total number of live births to adolescent women age 15-19 years old

Denominator:
Eligible population 15-19 years old (female only)

18
 Indicator Formula Target

Crude Birth Rate (CBR) Numerator: No target

Total number of live births in a given period

Denominator:
Total population

Z. Demographic

Number of Barangays Sum of all barangays in the country No target

Number of Health Centers Sum of all Health Centers (MHC, CHC, RHU) in the country No target

Number of Barangay Health Sum of all BHS in the country No target

Stations

Ratio of Public Health Worker to Numerator: Physician

Population Total number of Health Personnel (Doctors, Nurses, Midwives, Dentists, Medical 1:20,000
Technologist, Nutritionist, Sanitary Engineers, Sanitation Inspectors, and Active
BHW) Nurses
1:10,000
Denominator:
Population Midwives
1:5,000

Dentist
1:50,000

Med Tech
1:50,000

Nutritionist
1:20,000

RSI
1:20,000

BHW
1:20 HHs

AA. Morbidity

Morbidity Rate Numerator: No target

Number of new cases of diseases in a given period

Denominator:
Total Population

19